Two risk measurement tools can help clinicians to estimate COVID-19 mortality in hospitalized patients

As the COVID-19 pandemic continues, researchers have developed and validated two simple risk measurement tools to help clinicians more accurately estimate a hospitalized patient's COVID-19 risk of death.

The two measurement models are called COVID-NoLab and COVID-SimpleLab. In collaboration with the Biobanque Québécoise de la COVID-19 in Montreal, Quebec, Canada, researchers examined patient records of individuals receiving care for COVID-19 in 11 hospitals between March 2020 and February 2021. Patient records were separated into two groups, and each patient record was categorized as low-, moderate-, or high-risk, identified from both the COVID-NoLab and COVID-SimpleLab models.

Researchers found the two scoring systems could predict patient mortality rates with reasonable accuracy, offering clinicians a reliable way to quickly identify low-risk patients who could potentially be managed as outpatients in the event of a bed shortage. These prediction models may help decrease unnecessary hospital admissions during COVID-19 surges.

Journal reference:

Ebell, M.H., et al. (2022) External validation of the COVID-NoLab and COVID-SimpleLab prognostic tools. The Annals of Family Medicine.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Study finds a lower mortality rate among individuals with myocarditis after mRNA vaccination than those with viral infection–related myocarditis